日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic Benefit Ratings for FDA Breakthrough-Designated Devices

FDA突破性医疗器械的治疗获益评级

Kadakia, Kushal T; Swoboda, Christine M; Moneer, Osman; Dhruva, Sanket S; Ross, Joseph S; Krumholz, Harlan M; Burke, James F; Rathi, Vinay K

Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry

行业向医生支付的费用与PCSK9抑制剂、ARNI和DOAC处方模式之间的关系:来自NCDR PINNACLE注册研究的报告

Annapureddy, Amarnath R; Murugiah, Karthik; Zheng, Luke; Minges, Karl E; Grandhi, Gowtham R; Ross, Joseph S; Ahmad, Tariq; Rodwin, Benjamin A; Dhruva, Sanket S; Girotra, Saket; Dayoub, Elias J; Curtis, Jeptha P; Desai, Nihar R

Shared Decision-Making and Patient Decision Aids for Percutaneous Left Atrial Appendage Occlusion

经皮左心耳封堵术的共同决策和患者决策辅助

Rager, Joshua B; Huang, Chien-Yu; Zimmerman, Sarah; Dhruva, Sanket S; Freeman, James V; Matlock, Daniel D; Minges, Karl; Sandhu, Amneet; Spatz, Erica S; Varosy, Paul; Caverly, Tanner J

FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program

FDA突破性医疗器械计划下的治疗器械授权

Kadakia, Kushal T; Dhruva, Sanket S; Ross, Joseph S; Burke, James F; Johnston, James L; Ramachandran, Reshma; Krumholz, Harlan M; Rathi, Vinay K

Evaluation of Payer Policies to Reduce Low-Value Medical Device-Based Procedure Use

评估支付方政策以减少低价值医疗器械相关手术的使用

Dhruva, Sanket S; Tingley, Sarah R; Incze, Michael; Neuhaus, John M; Bachhuber, Marcus A; Redberg, Rita F

Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement

医院购置获得突破性医疗器械并获补充医疗保险报销的费用

Moneer, Osman; Kadakia, Kushal T; Dhruva, Sanket S; Ross, Joseph S; Roth, Leah M; Burke, James F; Rathi, Vinay K

Research Derived From Medicare's Coverage With Evidence Development Program

源自医疗保险循证发展计划的研究

Janda, Guneet S; Moneer, Osman; Mooghali, Maryam; Ramachandran, Reshma; Wallach, Joshua D; Dhruva, Sanket S; Ross, Joseph S

Nonconcurrent Control Use in FDA Approval of High-Risk Medical Devices

非同步对照在FDA批准高风险医疗器械中的应用

Mooghali, Maryam; Dhruva, Sanket S; Hakimian, Hollin R L; Rathi, Vinay K; Kadakia, Kushal T; Ross, Joseph S

Towards a dynamic model to estimate evolving risk of major bleeding after percutaneous coronary intervention

构建动态模型以评估经皮冠状动脉介入治疗后大出血风险的演变

Hurley, Nathan C; Desai, Nihar; Dhruva, Sanket S; Khera, Rohan; Schulz, Wade; Huang, Chenxi; Curtis, Jeptha; Masoudi, Frederick; Rumsfeld, John; Negahban, Sahand; Krumholz, Harlan M; Mortazavi, Bobak J

Understanding Transient Left Ventricular Ejection Fraction Reduction During Atrial Fibrillation With Artificial Intelligence

利用人工智能了解房颤期间短暂性左心室射血分数降低

Yuan, Neal; Hong, Gloria J; Vrudhula, Amey; Kwan, Alan C; Duffy, Grant; Botting, Patrick; Dhruva, Sanket S; Siegel, Robert J; Ouyang, David